Update on PIK3CA Inhibitor : Researchers & Clinicians : Lymphangiomatosis & Gorham's Disease Alliance

Update on PIK3CA Inhibitor (Alpelisib) in Lymphatic Anomalies

Guillaume Canaud, MD, PhD – Necker Hospital, University of Paris (France)

Our community impact!

Social Media Followers

3,482
Registry Participants

521
Funds Raised for Research

$970,000

Image Slideshow

2023 Scientific Conference
Get caught up! Watch the presentations from the 2023 Scientific Conference.
What are Complex Lymphatic Anomalies?
Just diagnosed with a CLA. Check out our Patient Guidebook in 9 languages.
Join a support group
LGDA has several support groups on Facebook to connect with other patients and families.

Go to Previous Slide Go to Next Slide